Considerations in the management of patients taking oral contraceptives.
Among the undesirable effects associated with the use of oral contraceptives are an increased incidence of thromboembolic events, an increased risk of myocardial infarction, and, in certain users, a significant elevation in blood pressure. An altered fibrinolytic activity may have a direct effect on the occurrence of localized osteitis, "dry sockets." It is also possible that gingival inflammation and loss of attachment may occur even under conditions of adequate plaque control. Salivary changes and alterations in the bony trabecular pattern of the mandible have been observed, but the clinical significance is as yet undetermined (Illustration).
D003276:Contraceptives, Oral / Q000009:adverse effects*; D003280:Contraceptives, Oral, Synthetic / Q000009:adverse effects*; D004368:Dry Socket / Q000139:chemically induced; D005260:Female; D005881:Gingiva / Q000187:drug effects; D005883:Gingival Crevicular Fluid / Q000187:drug effects; D005882:Gingival Diseases / Q000139:chemically induced; D006801:Humans; D006973:Hypertension / Q000139:chemically induced; D008334:Mandible / Q000187:drug effects; D009055:Mouth / Q000187:drug effects*; D009203:Myocardial Infarction / Q000139:chemically induced; D013923:Thromboembolism / Q000139:chemically induced; D014081:Tooth Extraction
D003276:Contraceptives, Oral; D003280:Contraceptives, Oral, Synthetic